BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18694659)

  • 1. A review of diagnostic imaging in melanoma.
    Dancey AL; Mahon BS; Rayatt SS
    J Plast Reconstr Aesthet Surg; 2008 Nov; 61(11):1275-83. PubMed ID: 18694659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
    Constantinidou A; Hofman M; O'Doherty M; Acland KM; Healy C; Harries M
    Melanoma Res; 2008 Feb; 18(1):56-60. PubMed ID: 18227709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
    Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
    Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging in cutaneous melanoma.
    Ho Shon IA; Chung DK; Saw RP; Thompson JF
    Nucl Med Commun; 2008 Oct; 29(10):847-76. PubMed ID: 18769303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical reappraisal of false negative sentinel lymph node biopsy in melanoma.
    Manca G; Romanini A; Rubello D; Mazzarri S; Boni G; Chiacchio S; Tredici M; Duce V; Tardelli E; Volterrani D; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):105-13. PubMed ID: 24835287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Preoperative PET/CT Staging in Sentinel Lymph Node-Positive Melanoma.
    Scheier BY; Lao CD; Kidwell KM; Redman BG
    JAMA Oncol; 2016 Jan; 2(1):136-7. PubMed ID: 26401901
    [No Abstract]   [Full Text] [Related]  

  • 7. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
    Patnana M; Bronstein Y; Szklaruk J; Bedi DG; Hwu WJ; Gershenwald JE; Prieto VG; Ng CS
    Clin Radiol; 2011 Mar; 66(3):224-36. PubMed ID: 21295201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB; Soo V; Kraas J; Shen P; Levine EA
    Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on diagnostic imaging for melanoma.
    Grasee EA; Wagner JD
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):49-60. PubMed ID: 15062287
    [No Abstract]   [Full Text] [Related]  

  • 10. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
    Hafner J
    Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel imaging techniques in melanoma.
    Essner R; Belhocine T; Scott AM; Even-Sapir E
    Surg Oncol Clin N Am; 2006 Apr; 15(2):253-83. PubMed ID: 16632214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET CT imaging in patients undergoing sentinel node biopsy for melanoma.
    Kell MR; Ridge JA; Joseph N; Sigurdson ER
    Eur J Surg Oncol; 2007 Sep; 33(7):911-3. PubMed ID: 17207956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The latest diagnostical methods and therapy in melanoma].
    Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
    Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of imaging methods in metastatic melanoma.
    Li Q; Yang J
    Onkologie; 2012; 35(9):522-6. PubMed ID: 23007153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
    Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integrated role of ultrasonography in the diagnosis of soft tissue metastases from melanoma: preliminary report of a single-center experience and literature review.
    Covarelli P; Burini G; Barberini F; Caracappa D; Boselli C; Noya G; Castellani E; Rulli A
    In Vivo; 2013; 27(6):827-33. PubMed ID: 24292589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
    Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
    Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiology of soft tissue tumors including melanoma.
    Shelly MJ; MacMahon PJ; Eustace S
    Cancer Treat Res; 2008; 143():423-52. PubMed ID: 18619227
    [No Abstract]   [Full Text] [Related]  

  • 19. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.